相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
Chao Ma et al.
CANCER DISCOVERY (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
Coinhibitory molecules in hematologic malignancies: targets for therapeutic intervention
Wieger J. Norde et al.
BLOOD (2012)
The HVEM network: new directions in targeting novel costimulatory/co-inhibitory molecules for cancer therapy
Christine Pasero et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
TGF-Beta: a Master Switch in Tumor Immunity
Margherita Gigante et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Inhibitory Receptors on Lymphocytes: Insights from Infections
Pamela M. Odorizzi et al.
JOURNAL OF IMMUNOLOGY (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
Yoav Peretz et al.
PLOS PATHOGENS (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
Takuya Yamamoto et al.
BLOOD (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells
Katarzyna Karwacz et al.
EMBO MOLECULAR MEDICINE (2011)
The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation
Marcos W. Steinberg et al.
IMMUNOLOGICAL REVIEWS (2011)
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
Paul F. Robbins et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Essential Role of E3 Ubiquitin Ligase Activity in Cbl-b-Regulated T Cell Functions
Magdalena Paolino et al.
JOURNAL OF IMMUNOLOGY (2011)
Active Immunotherapy Combined With Blockade of a Coinhibitory Pathway Achieves Regression of Large Tumor Masses in Cancer-prone Mice
Marcio O. Lasaro et al.
MOLECULAR THERAPY (2011)
Transcription factor Foxp1 exerts essential cell-intrinsic regulation of the quiescence of naive T cells
Xiaoming Feng et al.
NATURE IMMUNOLOGY (2011)
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells
Chao Ma et al.
NATURE MEDICINE (2011)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Abrogating Cbl-b in effector CD8+ T cells improves the efficacy of adoptive therapy of leukemia in mice
Ingunn M. Stromnes et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
BTLA mediates inhibition of human tumor-specific CD8(+) T cells that can be partially reversed by vaccination
Laurent Derre et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+T Cells Is Linked to Antigen Recognition and T Cell Differentiation
Bertram Bengsch et al.
PLOS PATHOGENS (2010)
Lack of specific γ-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation
William R. Burns et al.
BLOOD (2009)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
Regulation of T-cell tolerance by calcium/NFAT signaling
Ian Baine et al.
IMMUNOLOGICAL REVIEWS (2009)
Suppressors of cytokine signaling (SOCS) in T cell differentiation, maturation, and function
Douglas C. Palmer et al.
TRENDS IN IMMUNOLOGY (2009)
Regulatory T cell expression of herpesvirus entry mediator suppresses the function of B and T lymphocyte attenuator-positive effector T cells
Ran Tao et al.
JOURNAL OF IMMUNOLOGY (2008)
Direct multiplexed measurement of gene expression with color-coded probe pairs
Gary K. Geiss et al.
NATURE BIOTECHNOLOGY (2008)
The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20
Noula Shembade et al.
NATURE IMMUNOLOGY (2008)
CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator
Guifang Cai et al.
NATURE IMMUNOLOGY (2008)
T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α
Yuanyuan Zha et al.
NATURE IMMUNOLOGY (2006)
Disruption of diacylglycerol metabolism impairs the induction of T cell anergy
Benjamin A. Olenchock et al.
NATURE IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype
JG Casado et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Transition of late-stage effector T cells to CD27(+) CD28(+) tumor-reactive effector memory T cells in humans after adoptive cell transfer therapy
DJ Powell et al.
BLOOD (2005)
Inhibitory NK-cell receptors on T cells: Witness of the past, actors of the future
E Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Enhanced T cell responses due to diacylglycerol kinase ξ deficiency
XP Zhong et al.
NATURE IMMUNOLOGY (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
GJ Freeman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
